Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 159

1.

Device Legislation...... Now Tread Cautiously.

Judy KWM.

Implant Dent. 2019 Aug;28(4):317. doi: 10.1097/ID.0000000000000926. No abstract available.

PMID:
31205269
2.

Reflection and Transition.

Judy KWM.

Implant Dent. 2019 Jun;28(3):217. doi: 10.1097/ID.0000000000000899. No abstract available.

PMID:
31124817
3.

Guest Editorial: Icoi's evolving educational philosophy.

Judy KWM, Palti A.

Int J Oral Implantol (New Malden). 2019;12(1):7. No abstract available.

PMID:
31116184
4.

Laser Ablation of Abnormal Neurological Tissue Using Robotic Neuroblate System (LAANTERN): Procedural Safety and Hospitalization.

Rennert RC, Khan U, Bartek J Jr, Tatter SB, Field M, Toyota B, Fecci PE, Judy K, Mohammadi AM, Landazuri P, Sloan AE, Kim AH, Leuthardt EC, Chen CC.

Neurosurgery. 2019 May 11. pii: nyz141. doi: 10.1093/neuros/nyz141. [Epub ahead of print]

PMID:
31076762
5.

Reflection and Transition.

Judy KWM.

Implant Dent. 2019 Apr 20. doi: 10.1097/ID.0000000000000899. [Epub ahead of print] No abstract available.

PMID:
31021892
6.

Rapid Early Tumor Progression is Prognostic in Glioblastoma Patients.

Palmer JD, Bhamidipati D, Shukla G, Sharma D, Glass J, Kim L, Evans JJ, Judy K, Farrell C, Andrews DW, Wang ZW, Peiper SC, Werner-Wasik M, Shi W.

Am J Clin Oncol. 2019 May;42(5):481-486. doi: 10.1097/COC.0000000000000537.

PMID:
30973372
7.

Periimplant Disease: An ICOI/FDI Project.

Judy KWM.

Implant Dent. 2019 Apr;28(2):99. doi: 10.1097/ID.0000000000000880. No abstract available.

PMID:
30893138
8.

Phase I trial of alisertib with concurrent fractionated stereotactic re-irradiation for recurrent high grade gliomas.

Song A, Andrews DW, Werner-Wasik M, Kim L, Glass J, Bar-Ad V, Evans JJ, Farrell CJ, Judy KD, Daskalakis C, Zhan T, Shi W.

Radiother Oncol. 2019 Mar;132:135-141. doi: 10.1016/j.radonc.2018.12.019. Epub 2019 Jan 4.

PMID:
30825962
9.

Cerebral Amyloidoma Resulting from Central Nervous System Lymphoplasmacytic Lymphoma: A Case Report and Literature Review.

Jagannathan G, Uppal G, Judy K, Curtis MT.

Case Rep Pathol. 2018 Jun 26;2018:5083234. doi: 10.1155/2018/5083234. eCollection 2018.

10.

Patterns of Clinical Use of Stereotactic Laser Ablation: Analysis of a Multicenter Prospective Registry.

Rennert RC, Khan U, Tatter SB, Field M, Toyota B, Fecci PE, Judy K, Mohammadi AM, Landazuri P, Sloan A, Leuthardt E, Chen CC.

World Neurosurg. 2018 Aug;116:e566-e570. doi: 10.1016/j.wneu.2018.05.039. Epub 2018 May 14.

11.

Laser ablation after stereotactic radiosurgery: a multicenter prospective study in patients with metastatic brain tumors and radiation necrosis.

Ahluwalia M, Barnett GH, Deng D, Tatter SB, Laxton AW, Mohammadi AM, Leuthardt E, Chamoun R, Judy K, Asher A, Essig M, Dietrich J, Chiang VL.

J Neurosurg. 2018 May 4;130(3):804-811. doi: 10.3171/2017.11.JNS171273.

PMID:
29726782
12.

Correction to: Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.

Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW.

J Neurooncol. 2018 Mar;137(1):179. doi: 10.1007/s11060-018-2744-5.

PMID:
29313182
13.

Salvage fractionated stereotactic re-irradiation (FSRT) for patients with recurrent high grade gliomas progressed after bevacizumab treatment.

Shi W, Blomain ES, Siglin J, Palmer JD, Dan T, Wang Y, Werner-Wasik M, Glass J, Kim L, Bar Ad V, Bhamidipati D, Evans JJ, Judy K, Farrell CJ, Andrews DW.

J Neurooncol. 2018 Mar;137(1):171-177. doi: 10.1007/s11060-017-2709-0. Epub 2017 Dec 12. Erratum in: J Neurooncol. 2018 Jan 8;:.

PMID:
29235052
14.

Phase 1 Study of Ipilimumab Combined With Whole Brain Radiation Therapy or Radiosurgery for Melanoma Patients With Brain Metastases.

Williams NL, Wuthrick EJ, Kim H, Palmer JD, Garg S, Eldredge-Hindy H, Daskalakis C, Feeney KJ, Mastrangelo MJ, Kim LJ, Sato T, Kendra KL, Olencki T, Liebner DA, Farrell CJ, Evans JJ, Judy KD, Andrews DW, Dicker AP, Werner-Wasik M, Shi W.

Int J Radiat Oncol Biol Phys. 2017 Sep 1;99(1):22-30. doi: 10.1016/j.ijrobp.2017.05.028. Epub 2017 May 26.

PMID:
28816150
15.
16.

Never, Never, Never Give Up: Winston Churchill, October 29, 1941.

Judy KW.

Implant Dent. 2016 Aug;25(4):455. doi: 10.1097/ID.0000000000000449. No abstract available.

PMID:
27455427
17.

Fractionated Stereotactic Radiotherapy for Facial Nerve Schwannomas.

Shi W, Jain V, Kim H, Champ C, Jain G, Farrell C, Andrews DW, Judy K, Liu H, Artz G, Werner-Wasik M, Evans JJ.

J Neurol Surg B Skull Base. 2016 Feb;77(1):75-80. doi: 10.1055/s-0035-1564056. Epub 2015 Sep 14.

18.

Phase I trial of panobinostat and fractionated stereotactic re-irradiation therapy for recurrent high grade gliomas.

Shi W, Palmer JD, Werner-Wasik M, Andrews DW, Evans JJ, Glass J, Kim L, Bar-Ad V, Judy K, Farrell C, Simone N, Liu H, Dicker AP, Lawrence YR.

J Neurooncol. 2016 May;127(3):535-9. doi: 10.1007/s11060-016-2059-3. Epub 2016 Jan 29.

PMID:
26821711
19.

Tumor volume threshold for achieving improved conformity in VMAT and Gamma Knife stereotactic radiosurgery for vestibular schwannoma.

Kim H, Potrebko P, Rivera A, Liu H, Eldredge-Hindy HB, Gunn V, Werner-Wasik M, Andrews DW, Evans JJ, Farrell CJ, Judy K, Shi W.

Radiother Oncol. 2015 May;115(2):229-34. doi: 10.1016/j.radonc.2015.03.031. Epub 2015 May 18.

PMID:
25998805
20.

BCNU wafer placement with temozolomide (TMZ) in the immediate postoperative period after tumor resection followed by radiation therapy with TMZ in patients with newly diagnosed high grade glioma: final results of a prospective, multi-institutional, phase II trial.

Burri SH, Prabhu RS, Sumrall AL, Brick W, Blaker BD, Heideman BE Jr, Boltes P, Kelly R, Symanowski JT, Wiggins WF, Ashby L, Norton HJ, Judy K, Asher AL.

J Neurooncol. 2015 Jun;123(2):259-66. doi: 10.1007/s11060-015-1793-2. Epub 2015 May 7.

PMID:
25947286
21.

Cryptococcal ventriculoperitoneal shunt infection.

Viereck MJ, Chalouhi N, Krieger DI, Judy KD.

J Clin Neurosci. 2014 Nov;21(11):2020-1. doi: 10.1016/j.jocn.2014.08.001. Epub 2014 Sep 12.

PMID:
25220283
22.

Vorinostat as a radiosensitizer for brain metastasis: a phase I clinical trial.

Shi W, Lawrence YR, Choy H, Werner-Wasik M, Andrews DW, Evans JJ, Judy KD, Farrell CJ, Moshel Y, Berger AC, Bar-Ad V, Dicker AP.

J Neurooncol. 2014 Jun;118(2):313-319. doi: 10.1007/s11060-014-1433-2. Epub 2014 Apr 13.

PMID:
24728831
23.

Artificial intelligence versus editorial art.

Judy KW.

Implant Dent. 2012 Aug;21(4):255. doi: 10.1097/ID.0b013e3182622606. No abstract available.

PMID:
22814547
24.

Use of cone beam computed tomography in implant dentistry: the International Congress of Oral Implantologists consensus report.

Benavides E, Rios HF, Ganz SD, An CH, Resnik R, Reardon GT, Feldman SJ, Mah JK, Hatcher D, Kim MJ, Sohn DS, Palti A, Perel ML, Judy KW, Misch CE, Wang HL.

Implant Dent. 2012 Apr;21(2):78-86. doi: 10.1097/ID.0b013e31824885b5.

PMID:
22382748
25.

Unintentional injuries in pediatrics.

Judy K.

Pediatr Rev. 2011 Oct;32(10):431-8; quiz 439. doi: 10.1542/pir.32-10-431.

PMID:
21965710
26.

Clinically silent somatotroph adenomas are common.

Wade AN, Baccon J, Grady MS, Judy KD, O'Rourke DM, Snyder PJ.

Eur J Endocrinol. 2011 Jul;165(1):39-44. doi: 10.1530/EJE-11-0216. Epub 2011 Apr 14.

27.

Predictors of hearing loss after gamma knife radiosurgery for vestibular schwannomas: age, cochlear dose, and tumor coverage.

Brown M, Ruckenstein M, Bigelow D, Judy K, Wilson V, Alonso-Basanta M, Lee JY.

Neurosurgery. 2011 Sep;69(3):605-13; discussion 613-4. doi: 10.1227/NEU.0b013e31821a42f3.

PMID:
21471832
28.

Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging.

Wang S, Kim S, Chawla S, Wolf RL, Knipp DE, Vossough A, O'Rourke DM, Judy KD, Poptani H, Melhem ER.

AJNR Am J Neuroradiol. 2011 Mar;32(3):507-14. doi: 10.3174/ajnr.A2333. Epub 2011 Feb 17.

29.

Concurrent Cochlear Implantation with Resection of Skull Base Hemangiopericytoma following Sudden Deafness in an Only Hearing Ear.

Ransom ER, Judy KD, Bigelow DC.

Skull Base. 2010 Jul;20(4):279-84. doi: 10.1055/s-0030-1247633.

30.

Biodistribution and dosimetry of (18)F-EF5 in cancer patients with preliminary comparison of (18)F-EF5 uptake versus EF5 binding in human glioblastoma.

Koch CJ, Scheuermann JS, Divgi C, Judy KD, Kachur AV, Freifelder R, Reddin JS, Karp J, Stubbs JB, Hahn SM, Driesbaugh J, Smith D, Prendergast S, Evans SM.

Eur J Nucl Med Mol Imaging. 2010 Nov;37(11):2048-59. doi: 10.1007/s00259-010-1517-y. Epub 2010 Jun 29.

31.

The Relationship among Hypoxia, Proliferation, and Outcome in Patients with De Novo Glioblastoma: A Pilot Study.

Evans SM, Jenkins KW, Chen HI, Jenkins WT, Judy KD, Hwang WT, Lustig RA, Judkins AR, Grady MS, Hahn SM, Koch CJ.

Transl Oncol. 2010 Jun 1;3(3):160-9.

32.

Workplace violence: a survey of paediatric residents.

Judy K.

Med Teach. 2009 Nov;31(11):1038. No abstract available.

PMID:
19938239
33.

Systematic approach for the propagation of postgraduate dental implant education in developing countries.

Ogunsalu C, Judy K, Obiechina A, Daisely H, Bissoon AK, Steigmann M, Dosumu O, Okojie V, Akeredolu P.

Implant Dent. 2009 Jun;18(3):249-59. doi: 10.1097/ID.0b013e3181991096.

PMID:
19509535
34.

Workplace violence: a survey of paediatric residents.

Judy K, Veselik J.

Occup Med (Lond). 2009 Oct;59(7):472-5. doi: 10.1093/occmed/kqp068. Epub 2009 May 21.

PMID:
19460874
35.

Magnetic resonance perfusion-weighted imaging defines angiogenic subtypes of oligodendroglioma according to 1p19q and EGFR status.

Kapoor GS, Gocke TA, Chawla S, Whitmore RG, Nabavizadeh A, Krejza J, Lopinto J, Plaum J, Maloney-Wilensky E, Poptani H, Melhem ER, Judy KD, O'Rourke DM.

J Neurooncol. 2009 May;92(3):373-86. doi: 10.1007/s11060-009-9880-x. Epub 2009 Apr 9.

PMID:
19357963
36.

Imaging and analytical methods as applied to the evaluation of vasculature and hypoxia in human brain tumors.

Evans SM, Jenkins KW, Jenkins WT, Dilling T, Judy KD, Schrlau A, Judkins A, Hahn SM, Koch CJ.

Radiat Res. 2008 Dec;170(6):677-90. doi: 10.1667/RR1207.1.

37.

Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.

Chawla S, Oleaga L, Wang S, Krejza J, Wolf RL, Woo JH, O'Rourke DM, Judy KD, Grady MS, Melhem ER, Poptani H.

J Neuroimaging. 2010 Jan;20(1):3-8. doi: 10.1111/j.1552-6569.2008.00307.x.

PMID:
19021846
38.

Differentiation between glioblastomas and solitary brain metastases using diffusion tensor imaging.

Wang S, Kim S, Chawla S, Wolf RL, Zhang WG, O'Rourke DM, Judy KD, Melhem ER, Poptani H.

Neuroimage. 2009 Feb 1;44(3):653-60. doi: 10.1016/j.neuroimage.2008.09.027. Epub 2008 Oct 7.

39.

Guaranteeing treatment for everyone: the need for educational triage.

Judy KW.

Implant Dent. 2008 Mar;17(1):1. doi: 10.1097/ID.0b013e31816767bf. No abstract available.

PMID:
18332747
40.

A Phase I Trial of Ad.hIFN-β Gene Therapy for Glioma.

Chiocca EA, Smith KM, McKinney B, Palmer CA, Rosenfeld S, Lillehei K, Hamilton A, DeMasters BK, Judy K, Kirn D.

Mol Ther. 2008 Mar;16(3):618-626. doi: 10.1038/sj.mt.6300396. Epub 2016 Dec 8.

PMID:
28178503
41.

A phase I trial of Ad.hIFN-beta gene therapy for glioma.

Chiocca EA, Smith KM, McKinney B, Palmer CA, Rosenfeld S, Lillehei K, Hamilton A, DeMasters BK, Judy K, Kirn D.

Mol Ther. 2008 Mar;16(3):618-26. doi: 10.1038/sj.mt.6300396. Epub 2008 Jan 8.

42.

Arterial spin-labeling and MR spectroscopy in the differentiation of gliomas.

Chawla S, Wang S, Wolf RL, Woo JH, Wang J, O'Rourke DM, Judy KD, Grady MS, Melhem ER, Poptani H.

AJNR Am J Neuroradiol. 2007 Oct;28(9):1683-9. Epub 2007 Sep 24.

43.

Prediction of oligodendroglial tumor subtype and grade using perfusion weighted magnetic resonance imaging.

Whitmore RG, Krejza J, Kapoor GS, Huse J, Woo JH, Bloom S, Lopinto J, Wolf RL, Judy K, Rosenfeld MR, Biegel JA, Melhem ER, O'Rourke DM.

J Neurosurg. 2007 Sep;107(3):600-9.

PMID:
17886561
44.

Intraaxial brain masses: MR imaging-based diagnostic strategy--initial experience.

Al-Okaili RN, Krejza J, Woo JH, Wolf RL, O'Rourke DM, Judy KD, Poptani H, Melhem ER.

Radiology. 2007 May;243(2):539-50.

PMID:
17456876
45.
46.

Posterior fossa ependymoma.

Grady MS, Judy KD, Bigelow DC, Sinson GP, Rostomily R, Winn HR.

Skull Base. 2001 Aug;11(3):219-23. No abstract available.

47.

Stereotactic biopsy of brain stem masses: Decision analysis and literature review.

Samadani U, Stein S, Moonis G, Sonnad SS, Bonura P, Judy KD.

Surg Neurol. 2006 Nov;66(5):484-90; discussion 491.

PMID:
17084194
48.

Cerebrospinal fluid cytology to aid the diagnosis of cerebellopontine angle tumors.

Eisen MD, Smith PG, Judy KD, Bigelow DC.

Otol Neurotol. 2006 Jun;27(4):553-9.

PMID:
16791049
49.

Regional analysis of sinonasal ciliary beat frequency.

Shaari J, Palmer JN, Chiu AG, Judy KD, Cohen AS, Kennedy DW, Cohen NA.

Am J Rhinol. 2006 Mar-Apr;20(2):150-4.

PMID:
16686377
50.

Grading of CNS neoplasms using continuous arterial spin labeled perfusion MR imaging at 3 Tesla.

Wolf RL, Wang J, Wang S, Melhem ER, O'Rourke DM, Judy KD, Detre JA.

J Magn Reson Imaging. 2005 Oct;22(4):475-82.

PMID:
16161080

Supplemental Content

Support Center